Abstract
Inorganic polyphosphate (polyP) is a widely occurring but only rarely investigated biopolymer which exists in both prokaryotic and eukaryotic organisms. Only in the last few years, this polymer has been identified to cause morphogenetic activity on cells involved in human bone formation. The calcium complex of polyP was found to display a dual effect on bone-forming osteoblasts and bone-resorbing osteoclasts. Exposure of these cells to polyP (Ca2+ complex) elicits the expression of cytokines that promote the mineralization process by osteoblasts and suppress the differentiation of osteoclast precursor cells to the functionally active mature osteoclasts dissolving bone minerals. The effect of polyP on bone formation is associated with an increased release of the bone morphogenetic protein 2 (BMP-2), a key mediator that activates the anabolic processes leading to bone formation. In addition, polyP has been shown to act as a hemostatic regulator that displays various effects on blood coagulation and fibrinolysis and might play an important role in platelet-dependent proinflammatory and procoagulant disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrams SA (1998) Bone turnover during lactation-can calcium supplementation make a difference? J Clin Endocrinol Metab 83:1056–1058
Agholme F, Li X, Isaksson H, Ke HZ, Aspenberg P (2010) Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J Bone Miner Res 25:2412–2418
Ahn K, Kornberg A (1990) Polyphosphate kinase from Escherichia coli. Purification and demonstration of a phosphoenzyme intermediate. J Biol Chem 265:11734–11739
Anderson HC (1969) Vesicles associated with calcification in the matrix of epiphyseal cartilage. J Cell Biol 41:59–72
Anderson HC (1995) Molecular biology of matrix vesicles. Clin Orthop Relat Res 314:266–280
Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millán JL (2004) Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164:841–847
Banovac K, Koren E (2000) Triiodothyronine stimulates the release of membrane-bound alkaline phosphatase in osteoblastic cells. Calcif Tissue Int 67:460–465
Beck GR, Zerler B, Moran E (2000) Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA 97:8352–8357
Bellido T, Plotkin LI (2011) Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability. Bone 49:50–55
Bolander ME, Young MF, Fisher LW, Yamada Y, Termine JD (1988) Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (Ovomucoid). Proc Natl Acad Sci USA 85:2919–2923
Boskey A, Gadaleta S, Gundberg C, Doty S, Ducy P, Karsenty G (1998) Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23:187–196
Boyce BF, Xing L (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139–146
Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342
Bruedigam C, Eijken M, Koedam M, van de Peppel J, Drabek K, Chiba H, van Leeuwen JP (2010) A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone. Stem Cells 28:916–927
Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260–1268
Caen J, Wu Q (2010) Hageman factor, platelets and polyphosphates: early history and recent connection. J Thromb Haemost 8:1670–1674
Cerri PS, Boabaid F, Katchburian E (2003) Combined TUNEL and TRAP methods suggest that apoptotic bone cells are inside vacuoles of alveolar bone osteoclasts in young rats. J Periodontol Res 38:223–226
Chang W, Tu C, Chen TH, Komuves L, Oda Y, Pratt SA, Miller S, Shoback D (1999) Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 140:5883–5893
Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22:233–241
Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV (1994) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277–286
Choi HJ, Park YR, Nepal M, Choi BY, Cho NP, Choi SH, Heo SR, Kim HS, Yang MS, Soh Y (2010) Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-κB signaling pathways. Eur J Pharmacol 636:28–35
Choi SH, Smith SA, Morrissey JH (2011) Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 118:6963–6970
Cyboron GW, Wuthier RE (1981) Purification and initial characterization of intrinsic membrane-bound alkaline phosphatase from chicken epiphyseal cartilage. J Biol Chem 156:7262–7268
Dvorak MM, Riccardi D (2004) Ca2+ as an extracellular signal in bone. Cell Calcium 35:249–255
Felsenberg D, Boonen S (2005) The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther 27:1–11
Filgueira L (2004) Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. J Histochem Cytochem 52:411–414
Fleisch H (1999) From polyphosphates to bisphosphonates and their role in bone and calcium metabolism. In: Schröder HC, Müller WEG (eds) Inorganic polyphosphates biochemistry, biology, biotechnology. Springer, Heidelberg, pp 197–215
Fleisch H, Neuman WF (1961) Mechanisms of calcification: role of collagen, polyphosphates, and phosphatase. Am J Physiol 200:1296–1300
Fleisch H, Russel R, Straumann F (1966a) Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212:901–903
Fleisch H, Straumann F, Schenk R, Bisaz S, Allgöwer M (1966b) Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture. Am J Physiol 211:821–825
Garimella R, Tague SE, Zhang J, Belibi F, Nahar N, Sun Ben H, Insogna K, Wang J, Anderson HC (2008) Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling. J Histochem Cytochem 56:569–577
Ghosh S, Karin M (2002) Missing pieces in the NF-κB puzzle. Cell 109(Suppl):S81–S96
Graff RD, Picher M, Lee GM (2003) Extracellular nucleotides, cartilage stress, and calcium crystal formation. Curr Opin Rheumatol 15:315–320
Griffith EJ (1995) Phosphate fibers, Topics in applied chemistry. Springer, Berlin
Hacchou Y, Uematsu T, Ueda O, Usui Y, Uematsu S, Takahashi M, Uchihashi T, Kawazoe Y, Shiba T, Kurihara S, Yamaoka M, Furusawa K (2007) Inorganic polyphosphate: a possible stimulant of bone formation. J Dent Res 86:893–897
Han KY, Hong BS, Yoon YJ, Yoon CM, Kim YK, Kwon YG, Gho YS (2007) Polyphosphate blocks tumour metastasis via anti-angiogenic activity. Biochem J 406:49–55
Hausser HJ, Brenner RE (2005) Phenotypic instability of SaOS-2 cells in long-term culture. Biochem Biophys Res Commun 333:216–222
Hayase Y, Muguruma Y, Lee MY (1997) Osteoclast development from hematopoietic stem cells: apparent divergence of the osteoclast lineage prior to macrophage commitment. Exp Hematol 25:19–25
Henthorn PS (1996) Alkaline phosphatase. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of bone biology, 1st edn. Academic, San Diego, CA, pp 197–206
Hernandez-Ruiz L, González-García I, Castro C, Brieva JA, Ruiz FA (2006) Inorganic polyphosphate and specific induction of apoptosis in human plasma cells. Haematologica 91:1180–1186
Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99:9445–9449
Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY, Guo LJ, Xie H, Zhou HD, Wu XP, Luo XH (2011) A RUNX2/MIR-3960/MIR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 286:12328–12339
Hui M, Tenenbaum HC (1998) New face of an old enzyme: alkaline phosphatases may contribute to human tissue aging by inducing tissue hardening and calcification. Anat Rec 253:91–94
Imsiecke G, Münkner J, Lorenz B, Bachinski N, Müller WEG, Schröder HC (1996) Inorganic polyphosphates in the developing freshwater sponge Ephydatia muelleri: effect of stress by polluted waters. Environ Toxicol Chem 15:1329–1334
Jabbar S, Drury J, Fordham JN, Datta HK, Francis RM, Tuck SP (2011) Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. J Clin Pathol 64:354–357
Jang WG, Kim EJ, Kim DK, Ryoo HM, Lee KB, Kim SH, Choi HS, Koh JT (2012) BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription. J Biol Chem 287:905–915
Jimenez-Nunez MD, Moreno-Sanchez D, Hernandez-Ruiz L, Benitez-Rondan A, Ramos-Amaya A, Rodriguez-Bayona B, Medina F, Brieva JA, Ruiz FA (2012) Myeloma cells contain high inorganic polyphosphate levels that are associated with nucleolar transcription. Haematologica 97:1264–1271
Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millan JL, Terkeltaub R (2000) Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 279:R1365–R1377
Kanis JA (1994) WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4:368–381
Kasuyama K, Tomofuji T, Ekuni D, Azuma T, Irie K, Endo Y, Morita M (2012) Effects of topical application of inorganic polyphosphate on tissue remodeling in rat inflamed gingiva. J Periodontal Res 47:159–164
Katchman BJ, Smith HE (1958) Diffusion of synthetic and natural polyphosphates. Arch Biochem Biophys 76:396–402
Kawazoe Y, Shiba T, Nakamura R, Mizuno A, Tsutsumi K, Uematsu T, Yamaoka M, Shindoh M, Kohgo T (2004) Induction of calcification in MC3T3-E1 cells by inorganic polyphosphate. J Dent Res 83:613–618
Kawazoe Y, Katoh S, Onodera Y, Kohgo T, Shindoh M, Shiba T (2008) Activation of the FGF signaling pathway and subsequent induction of mesenchymal stem cell differentiation by inorganic polyphosphate. Int J Biol Sci 4:37–47
Kearns AE, Khosla S, Kostenuik PJ (2008) Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29:155–192
Kelly SE, Di Benedetto A, Greco A, Howard CM, Sollars VE, Primerano DA, Valluri JV, Claudio PP (2010) Rapid selection and proliferation of CD133(+) cells from cancer cell lines: chemotherapeutic implications. PLoS One 5:e10035
Kornberg A (1999) Inorganic polyphosphate: a molecule of many functions. In: Schröder HC, Müller WEG (eds) Inorganic polyphosphates: biochemistry, biology, biotechnology, vol 23, Progress in molecular subcellular biology. Springer, Berlin, pp 1–26
Krasko A, Batel R, Schröder HC, Müller IM, Müller WEG (2000) Expression of silicatein and collagen genes in the marine sponge Suberites domuncula is controlled by silicate and myotrophin. Eur J Biochem 267:4878–4887
Kulaev IS (1979) The biochemistry of inorganic polyphosphates. Wiley, New York, NY
Kulaev IS, Vagabov VM, Kulakovskaya TV (2004) The biochemistry of inorganic polyphosphates. Wiley, Chichester, pp 1–277
Kulakovskaya TV, Vagabov VM, Kulaev IS (2012) Inorganic polyphosphate in industry, agriculture and medicine: modern state and outlook. Process Biochem 47:1–10
Kumble KD, Kornberg A (1995) Inorganic polyphosphate in mammalian cells and tissues. J Biol Chem 270:5818–5822
Laitinen M, Jortikka L, Halttunen T, Böhling T, Marttinen A, Lindholm TS (1997) Soluble factors from human Saos-2 osteosarcoma cells induce ectopic bone formation and osteoblastic differentiation of cultured mesenchymal cells. J Musculoskelet Res 1:21–32
Landis WJ, Hodgens KJ, Song MJ, Arena J, Kiyonaga S, Marko M, Owen C, McEwen BF (1996) Mineralization of collagen may occur on fibril surfaces: evidence from conventional and high-voltage electron microscopy and three-dimensional imaging. J Struct Biol 117:24–35
Lane NE, Yao W (2009) Developments in the scientific understanding of osteoporosis. Arthritis Res Ther 11:228
Lee ZH, Kim HH (2003) Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305:211–214
Lee J, Park JB, Herr Y, Chung JH, Kwon YH (2008) The effect of polyphosphate on exophytic bone formation. J Korean Acad Periodontol 38:59–66
Lee BH, Kim MC, Choi SH, Lee YK (2009) Amorphous calcium polyphosphate bone regenerative materials based on calcium phosphate glass. Key Eng Mater 396–398:209–212
Lee SJ, Kang SW, Do HJ, Han I, Shin DA, Kim JH, Lee SH (2010) Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells. Biomaterials 31:5652–5659
Leyhausen G, Lorenz B, Zhu H, Geurtsen W, Bohnensack R, Müller WEG, Schröder HC (1998) Inorganic polyphosphate in human osteoblast-like cells. J Bone Miner Res 13:803–812
Lorch IJ (1949) Alkaline phosphatase and the mechanism of ossification. J Bone Joint Surg 31:94–99
Lorenz B, Schröder HC (1999) Methods for investigation of inorganic polyphosphates and polyphosphate-metabolizing enzymes. In: Schröder HC, Müller WEG (eds) Inorganic polyphosphates—biochemistry, biology, biotechnology, Prog Mol Subcell Biol 23: 217–239
Lorenz B, Schröder HC (2001) Mammalian intestinal alkaline phosphatase acts as highly active exopolyphosphatase. Biochim Biophys Acta 1547:254–261
Lorenz B, Marmé S, Müller WEG, Unger K, Schröder HC (1994a) Preparation and use of polyphosphate-modified zirconia for purification of nucleic acids and proteins. Anal Biochem 216:118–126
Lorenz B, Müller WEG, Kulaev IS, Schröder HC (1994b) Purification and characterization of an exopolyphosphatase activity from Saccharomyces cerevisiae. J Biol Chem 269:22198–22204
Lorenz B, Batel R, Bachinski N, Müller WEG, Schröder HC (1995) Purification and characterization of two exopolyphosphatases from the marine sponge Tethya lyncurium. Biochim Biophys Acta 1245:17–28
Lorenz B, Leuck J, Köhl D, Müller WEG, Schröder HC (1997a) Anti-HIV-1 activity of inorganic polyphosphates. J Acquir Immune Defic Syndr Hum Retrovirol 14:110–118
Lorenz B, Münkner J, Oliveira MP, Kuusksalu A, Leitão JM, Müller WEG, Schröder HC (1997b) Changes in metabolism of inorganic polyphosphate in rat tissues and human cells during development and apoptosis. Biochim Biophys Acta 1335:51–60
Lorenz B, Münkner J, Oliveira MP, Leitão JM, Müller WEG, Schröder HC (1997c) A novel method for determination of inorganic polyphosphates using the fluorescent dye fura-2. Anal Biochem 246:176–184
Lymperi S, Ersek A, Ferraro F, Dazzi F, Horwood NJ (2011) Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 117:1540–1549
Maekawa K, Yoshida Y, Mine A, Fujisawa T, Van Meerbeek B, Suzuki K, Kuboki T (2007) Chemical interaction of polyphosphoric acid with titanium and its effect on human bone marrow derived mesenchymal stem cell behavior. J Biomed Mater Res A 82:195–200
Maekawa K, Yoshida Y, Mine A, van Meerbeek B, Suzuki K, Kuboki T (2008) Effect of polyphosphoric acid pre-treatment of titanium on attachment, proliferation, and differentiation of osteoblast-like cells (MC3T3-E1). Clin Oral Implants Res 19:320–325
Maekawa K, Shimono K, Oshima M, Yoshida Y, Van Meerbeek B, Suzuki K, Kuboki T (2009) Polyphosphoric acid treatment promotes bone regeneration around titanium implants. J Oral Rehabil 36:362–367
Millan JL (2006) Alkaline phosphatases. Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2:335–341
Morgan EF, Barnes GL, Einhorn TA (2008) The bone organ system: form and function. In: Marcus R, Feldman D, Nelson D, Rosen CJ (eds) Osteoporosis, 3rd edn. Elsevier Academic, Boston, MA, pp 3–25
Morimoto D, Tomita T, Kuroda S, Higuchi C, Kato S, Shiba T, Nakagami H, Morishita R, Yoshikawa H (2010) Inorganic polyphosphate differentiates human mesenchymal stem cells into osteoblastic cells. J Bone Miner Metab 28:418–423
Morita K, Doi K, Kubo T, Takeshita R, Kato S, Shiba T, Akagawa Y (2010) Enhanced initial bone regeneration with inorganic polyphosphate-adsorbed hydroxyapatite. Acta Biomater 6:2808–2815
Morrissey JH (2012) Polyphosphate: a link between platelets, coagulation and inflammation. Int J Hematol 95:346–352
Morse DE (1999) Silicon biotechnology: harnessing biological silica production to construct new materials. Trends Biotechnol 17:230–232
Müller F, Renné T (2011) Platelet polyphosphates: the nexus of primary and secondary hemostasis. Scand J Clin Lab Invest 71:82–86
Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renné T (2009a) Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139:1143–1156
Müller WEG, Wang XH, Cui FZ, Jochum KP, Tremel W, Bill J, Schröder HC, Natalio F, Schloßmacher U, Wiens M (2009b) Sponge spicules as blueprints for the biofabrication of inorganic-organic composites and biomaterials. Appl Microbiol Biotechnol 83:397–413
Müller WEG, Wang XH, Diehl-Seifert B, Kropf K, Schloßmacher U, Lieberwirth I, Glasser G, Wiens M, Schröder HC (2011) Inorganic polymeric phosphate/polyphosphate as an inducer of alkaline phosphatase and a modulator of intracellular Ca2+ level in osteoblasts (SaOS-2 cells) in vitro. Acta Biomater 7:2661–2671
Müller WEG, Wang XH, Guo YW, Schröder HC (2012) Potentiation of the cytotoxic activity of copper by polyphosphate on biofilm-producing bacteria: a bioinspired approach. Mar Drugs 10:2369–2387
Müller WEG, Schröder HC, Burghard Z, Pisignano D, Wang XH (2013a) Silicateins: a paradigm shift in bioinorganic chemistry. Enzymatic synthesis of inorganic polymeric silica. Chem Eur J 19:5790–5804
Müller WEG, Schröder HC, Schlossmacher U, Grebenjuk VA, Ushijima H, Wang XH (2013b) Induction of carbonic anhydrase in SaOS-2 cells, exposed to bicarbonate and consequences for calcium phosphate crystal formation. Biomaterials 34:8671–8680
Mutch NJ, Engel R, Uitte de Willige S, Philippou H, Ariëns RA (2010) Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood 115:3980–3988
Nam HK, Liu J, Li Y, Kragor A, Hatch NE (2011) Ectonucleotide pyrophosphatase/ phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation. J Biol Chem 286:39059–39071
Nickel J, Dreyer MK, Kirsch T, Sebald W (2001) The crystal structure of the BMP-2–BMPR-IA complex and the generation of BMP-2 antagonists. J Bone Joint Surg Am 83-A(Suppl 1):S7–S14
Oldberg A, Franzen A, Heinegard D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819–8823
Oldberg A, Franzen A, Heinegard D (1988) The primary structure of a cell binding bone sialoprotein. J Biol Chem 263:19430–19432
Omelon SJ, Grynpas MD (2008) Relationships between polyphosphate chemistry, biochemistry and apatite biomineralization. Chem Rev 108:4694–4715
Omelon S, Georgiou J, Henneman ZJ, Wise LM, Sukhu B, Hunt T, Wynnyckyj C, Holmyard D, Ryszard B, Grynpas MD (2009) Control of vertebrate skeletal mineralization by polyphosphates. PLoS One 4:e5634
Ominsky MS, Stolina M, Li X, Corbin TJ, Asuncion FJ, Barrero M, Niu QT, Dwyer D, Adamu S, Warmington KS, Grisanti M, Tan HL, Ke HZ, Simonet WS, Kostenuik PJ (2009) One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength. J Bone Miner Res 24:1234–1246
Omoto M, Imai T, Seki K, Nomura R, Otahara Y (1997) The effect on the bones of condensed phosphate when used as food additives: its importance in relation to preventive medicine. Environ Health Prev Med 2:105–116
Orimo H, Shimada T (2008) The role of tissue-nonspecific alkaline phosphatase in the phosphate-induced activation of alkaline phosphatase and mineralization in SaOS-2 human osteoblast-like cells. Mol Cell Biochem 282:101–108
Palmer G, Bonjour JP, Caverzasio J (1997) Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-Like cells and its regulation by insulin-like growth factor I. Endocrinology 138:5202–5209
Pavlov E, Aschar-Sobbi R, Campanella M, Turner RJ, Gómez-García MR, Abramov AY (2010) Inorganic polyphosphate and energy metabolism in mammalian cells. J Biol Chem 285:9420–9428
Price CP (1993) Multiple forms of human serum alkaline phosphatase: detection and quantitation. Ann Clin Biochem 30:355–372
Quinn JM, Gillespie MT (2005) Modulation of osteoclast formation. Biochem Biophys Res Commun 328:739–745
Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325
Ramos I, Gomes F, Koeller CM, Saito K, Heise N, Masuda H, Docampo R, de Souza W, Machado EA, Miranda K (2011) Acidocalcisomes as calcium- and polyphosphate-storage compartments during embryogenesis of the insect Rhodnius prolixus Stahl. PLoS One 6:e27276
Rao NN, Gómez-Garcıa MR, Kornberg A (2009) Inorganic polyphosphate: essential for growth and survival. Annu Rev Biochem 78:605–647
Register TC, Wuthier RE (1985) Effect of pyrophosphate and two diphosphonates on 45Ca and 32Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite. Bone 6:307–312
Rezende LA, Ciancaglini P, Pizauro JM, Leone FA (1998) Inorganic pyrophosphate-phosphohydrolytic activity associated with rat osseous plate alkaline phosphatase. Cell Mol Biol (Noisy-le-grand) 44:293–302
Robey PG (2002) Bone matrix proteoglycans and glycoproteins. In: Bilezikan JP, Raisz LG, Rodan GA (eds) Principles of bone biology. Academic, San Diego, CA, p 225
Robins SP, Bilezikian JP, Seibel MJ (2006) Dynamics of bone and cartilage metabolism: principals and clinical applications. Academic, San Diego, CA
Rohde M, Mayer H (2007) Exocytotic process as a novel model for mineralization by osteoblasts in vitro and in vivo determined by electron microscopic analysis. Calcif Tissue Int 80:323–336
Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632–7636
Ruiz FA, Lea CR, Oldfield E, Docampo R (2004) Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem 279:44250–44257
Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367:2010–2018
Santini D, Schiavon G, Vincenzi B, Gaeta L, Pantano F, Russo A, Ortega C, Porta C, Galluzzo S, Armento G, La Verde N, Caroti C, Treilleux I, Ruggiero A, Perrone G, Addeo R, Clezardin P, Muda AO, Tonini G (2011) Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. PLoS One 6:e19234
Schröder HC, Müller WEG (eds) (1999) Inorganic polyphosphates: biochemistry. biology. biotechnology, Prog Mol Subcell Biol, vol 23. Springer, Berlin
Schröder HC, Lorenz B, Kurz L, Müller WEG (1999) Inorganic polyP in eukaryotes: enzymes, metabolism and function. In: Schröder HC, Müller WEG (eds) Inorganic polyphosphates—biochemistry, biology, biotechnology, Prog Mol Subcell Biol 23: 45–81
Schröder HC, Kurz L, Müller WEG, Lorenz B (2000) Polyphosphate in bone. Biochemistry (Moscow) 65:296–303
Schröder HC, Borejko A, Krasko A, Reiber A, Schwertner H, Müller WEG (2005) Mineralization of SaOS-2 cells on enzymatically (Silicatein) modified bioactive osteoblast-stimulating surfaces. J Biomed Mater Res B Appl Biomater 75B:387–392
Schröder HC, Wiens M, Wang XH, Schloßmacher U, Müller WEG (2011) In: Müller WEG (ed) Molecular biomineralization, Prog Mol Subcell Biol 52: 283–312
Schröder HC, Wang XH, Manfrin A, Yu SH, Grebenjuk VA, Korzhev M, Wiens M, Schloßmacher U, Müller WEG (2012a) Silicatein: acquisition of structure-guiding and structure-forming properties during maturation from the pro-silicatein to the silicatein form. J Biol Chem 287:22196–22205
Schröder HC, Wang XH, Wiens M, Diehl-Seifert B, Kropf K, Schloßmacher U, Müller WEG (2012b) Silicate modulates the cross-talk between osteoblasts (SaOS-2) and osteoclasts (RAW 264.7 cells): inhibition of osteoclast growth and differentiation. J Cell Biochem 113:3197–3206
Schröder HC, Wiens M, Schloßmacher U, Brandt D, Müller WEG (2012c) Silicatein-mediated polycondensation of orthosilicic acid: modeling of a catalytic mechanism involving ring formation. Silicon 4:33–38
Seidlmayer LK, Gomez-Garcia MR, Blatter LA, Pavlov E, Dedkova EN (2012) Inorganic polyphosphate is a potent activator of the mitochondrial permeability transition pore in cardiac myocytes. J Gen Physiol 139:321–331
Shahidi F, Rubin LJ, Diosady LL, Kassam N, Fong JC, Li S, Wood DF (1986) Effect of sequestering agents on lipid oxidation in cooked meats. Food Chem 21:145–152
Shiba T, Nishimura D, Kawazoe Y, Onodera Y, Tsutsumi K, Nakamura R, Ohshiro M (2003) Modulation of mitogenic activity of fibroblast growth factors by inorganic polyphosphate. J Biol Chem 278:26788–26792
Shimizu K, Cha J, Stucky GD, Morse DE (1998) Silicatein alpha: cathepsin L-like protein in sponge biosilica. Proc Natl Acad Sci USA 95:6234–6238
Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H (1995) ß-Glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15:2003–2009
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319
Sinha KM, Yasuda H, Coombes MM, Dent SYR, de Crombrugghe B (2010) Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J 29:68–79
Smith SA, Morrissey JH (2008) Polyphosphate as a general procoagulant agent. J Thromb Haemost 6:1750–1756
Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH (2006) Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 103:903–908
Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, Morrissey JH (2010) Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 116:4353–4359
Sodek J, Ganss B, McKee MD (2000) Osteopontin. Crit Rev Oral Biol Med 11:279–303
Sperow JW, Moe OA, Ridlington JW, Butler LG (1973) Yeast inorganic pyrophosphatase. VI. Studies on specificity and mechanism. J Biol Chem 248:2062–2065
St-Pierre JP, Wang Q, Li SQ, Pilliar RM, Kandel RA (2012) Inorganic polyphosphate stimulates cartilage tissue formation. Tissue Eng Part A 18:1282–1292
Sun L, Blair HC, Peng Y, Zaidi N, Adebanjo OA, Wu XB, Wu XY, Iqbal J, Epstein S, Abe E, Moong BS, Zaidi M (2005) Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci USA 102:17130–17135
Sung B, Murakami A, Oyajobi BO, Aggarwal BB (2009) Zerumbone abolishes RANKL-induced NF-κB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice. Cancer Res 69:1477–1484
Tammenkoski M, Koivula K, Cusanelli E, Zollo M, Steegborn C, Baykov AA, Lahti R (2008) Human metastasis regulator protein H-prune is a short-chain exopolyphosphatase. Biochemistry 47:9707–9713
Teitelbaum SL (2007) Osteoclasts: what do they do and how do they do it? Am J Pathol 170:427–435
Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K (1997) Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137–142
Usui Y, Uematsu T, Uchihashi T, Takahashi M, Takahashi M, Ishizuka M, Doto R, Tanaka H, Komazaki Y, Osawa M, Yamada K, Yamaoka M, Furusawa K (2010) Inorganic polyphosphate induces osteoblastic differentiation. J Dent Res 89:504–509
Vaisman DN, McCarthy AD, Cortizo AM (2005) Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates; role of divalent cations. Biol Trace Elem Res 104:131–140
Van Wazer JR (ed) (1958) Phosphorus and its compounds: chemistry, vol 1. Interscience Publishers Inc., New York, NY
Veldman CM, Markovich D, Schmid C, Murer H (1995) Expression of sodium dependent phosphate (NadPi) transport in Xenopus laevis oocytes induced by mRNA from 1α,25-dihydroxyvitamin D3-treated rat osteoblast-like cells. Pflügers Arch 430:64–67
Vincent C, Kogawa M, Findlay DM, Atkins GJ (2009) The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions. J Bone Miner Metab 27:114–119
Wang G, Yang J (2010) Influences of binder on fire protection and anticorrosion properties of intumescent fire resistive coating for steel structure. Surf Coat Technol 204:1186–1192
Wang Z, Li X, Li Z, Yang L, Sasaki Y, Wang S, Zhou L, Araki S, Mezawa M, Takai H, Ogata Y (2010) Effects of inorganic polyphosphate on bone sialoprotein gene expression. Gene 452:79–86
Wang XH, Schröder HC, Diehl-Seifert B, Kropf K, Schloßmacher U, Wiens M, Müller WEG (2012a) Dual effect of inorganic polymeric phosphate/polyphosphate on osteoblasts and osteoclasts in vitro. J Tissue Eng Regen Med 7:767–776
Wang XH, Schröder HC, Wiens M, Ushijima H, Müller WEG (2012b) Bio-silica and bio-polyphosphate: applications in biomedicine (bone formation). Curr Opin Biotechnol 23:570–578
Wang XH, Schröder HC, Feng QL, Draenert F, Müller WEG (2013) The deep-sea natural products, biogenic polyphosphate (bio-polyP) and biogenic silica (bio-silica) as biomimetic scaffolds for bone tissue engineering: fabrication of a morphogenetically-active polymer. Mar Drugs 11:718–746
Wiens M, Wang X, Natalio F, Schröder HC, Schloßmacher U, Wang S, Korzhev M, Geurtsen W, Müller WEG (2010a) Bioinspired fabrication of bio-silica-based bone substitution materials. Adv Eng Mater 12:B438–B450
Wiens M, Wang XH, Schloßmacher U, Lieberwirth I, Glasser G, Ushijima H, Schröder HC, Müller WEG (2010b) Osteogenic potential of bio-silica on human osteoblast-like (SaOS-2) cells. Calcif Tissue Int 87:513–524
Wiens M, Wang XH, Schröder HC, Kolb U, Schloßmacher U, Ushijima H, Müller WEG (2010c) The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblastlike cells. Biomaterials 31:7716–7725
Williams G, Sallis JD (1982) Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation. Calcif Tissue Int 34:169–177
Wood HG, Clark JE (1988) Biological aspects of inorganic polyphosphates. Annu Rev Biochem 57:235–260
Wu LNY, Valhmu WB, Lloyd GC, Genge BR, Wuthier RE (1989) Isolation of two glycosylated forms of membrane-bound alkaline phosphatase from avian growth plate cartilage matrix vesicle-enriched microsomes. Bone Miner 7:113–125
Wuthier RE, Makjeska RJ, Collins GM (1977) Biosynthesis of matrix vesicles in epiphyseal cartilage. I. In vivo incorporation of 32P orthophosphate into phospholipids of chondrocyte, membrane, and matrix vesicle fractions. Calcif Tissue Res 23:135–139
Yuan Q, Kubo T, Doi K, Morita K, Takeshita R, Katoh S, Shiba T, Gong P, Akagawa Y (2009) Effect of combined application of bFGF and inorganic polyphosphate on bioactivities of osteoblasts and initial bone regeneration. Acta Biomater 5:1716–1724
Zakharian E, Thyagarajan B, French RJ, Pavlov E, Rohacs T (2009) Inorganic polyphosphate modulates TRPM8 channels. PLoS One 4:e5404
Zhou Z, Han JY, Xi CX, Xie JX, Feng X, Wang CY, Mei L, Xiong WC (2008) HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE. J Bone Miner Res 23:1084–1096
Acknowledgments
W.E.G.M. is a holder of an ERC Advanced Investigator Grant (no. 268476 BIOSILICA) as well as of an ERC Proof-of-Concept grant (no. 324564). This work was supported by grants from the European Commission (large-scale integrating project no. 311848, BlueGenics; project no. FP7-KBBE-2010-4-266033, SPECIAL; project no. PIRSES-GA-2009-246987, European-Chinese Research Staff Exchange Cluster MarBioTec*EU-CN*), the German Bundesministerium für Bildung und Forschung – International Bureau (no. CHN 09/1AP, German-Chinese Joint Lab on Bio-Nano-Composites), the Public Welfare Project of Ministry of Land and Resources of the People’s Republic of China (grant no. 201011005-06), and the International S & T Cooperation Program of China (grant no. 2008DFA00980).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wang, X., Schröder, H.C., Schloßmacher, U., Müller, W.E.G. (2013). Inorganic Polyphosphates: Biologically Active Biopolymers for Biomedical Applications. In: Müller, W., Wang, X., Schröder, H. (eds) Biomedical Inorganic Polymers. Progress in Molecular and Subcellular Biology, vol 54. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41004-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-41004-8_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41003-1
Online ISBN: 978-3-642-41004-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)